Breaking News

Cobra’s Keele Bio-Facility Passes Inspection

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has completed a successful audit of Cobra Biomanufacturing’s facility in Keele.

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has completed a successful audit of Cobra Biomanufacturing’s facility in Keele. The authorization followed a three-day inspection and evaluation of the company’s manufacturing, analytical and quality management systems, which demonstrated that the facilities meet cGMP standards.

Simon Saxby, chief executive officer of Cobra Biomanufacturing, said, “This is excellent news and ongoing confirmation of the commitment of the company to meet the needs of worldwide Regulatory agencies. The renewal of our Manufacturers and Importers Authorization for Investigational Medicinal Products MIA (IMP) license acknowledges almost 10 years of cGMP compliance at Cobra and provision of a reliable and responsive biomanufacturing service to over 75 clients worldwide.”

Sign up today for Contracting & Outsourcing 2009!
contractpharma.com/2009conference

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters